We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+10.54%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.51B
AUM Growth
+$157M
(+12%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
8.67%
Top 10 Holdings %
Top 10 Hldgs %
43.35%
Holding
93
New
19
Increased
39
Reduced
13
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CUTR
Cutera, Inc.
CUTR
|
+$36.8M |
| 2 |
Aldeyra Therapeutics
ALDX
|
+$30.2M |
| 3 |
Sutro Biopharma
STRO
|
+$29.2M |
| 4 |
NeoGenomics
NEO
|
+$25.3M |
| 5 |
MODN
MODEL N, INC.
MODN
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$86.4M |
| 2 |
CareDx
CDNA
|
+$44.6M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
+$26.6M |
| 4 |
Halozyme
HALO
|
+$25.6M |
| 5 |
Arrowhead Research
ARWR
|
+$13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 84.27% |
| 2 | Communication Services | 4.55% |
| 3 | Energy | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
908 Devices
MASS
$329M
| $1M | 0.07% |
20,700
-59,300
| -74% | -$3.39M |
|
52
AbbVie
ABBV
$443B
| $647K | 0.04% |
5,981
| – | – |
|
53
Integer Holdings
ITGR
$4.12B
| $538K | 0.04% |
+5,846
| New | +$494K |
|
|
NUVA
54
DELISTED
NuVasive, Inc.
NUVA
| $515K | 0.03% |
7,850
+2,622
| +50% | +$157K |
|
55
Baxter International
BAX
$13.5B
| $500K | 0.03% |
5,929
+2,671
| +82% | +$212K |
|
56
Envista
NVST
$4.44B
| $481K | 0.03% |
11,793
+2,808
| +31% | +$107K |
|
|
HRC
57
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $480K | 0.03% |
4,346
+2,225
| +105% | +$232K |
|
58
Cigna
CI
$73.7B
| $470K | 0.03% |
1,943
+383
| +25% | +$85.4K |
|
59
Bristol-Myers Squibb
BMY
$133B
| $458K | 0.03% |
+7,256
| New | +$451K |
|
60
GSK
GSK
$104B
| $449K | 0.03% |
+10,059
| New | +$457K |
|
61
Elevance Health
ELV
$81.5B
| $447K | 0.03% |
1,244
| – | – |
|
62
Waters Corp
WAT
$37B
| $436K | 0.03% |
+1,536
| New | +$419K |
|
|
HOLX
63
DELISTED
Hologic
HOLX
| $435K | 0.03% |
5,845
+2,505
| +75% | +$190K |
|
|
SYNH
64
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $435K | 0.03% |
5,736
+1,267
| +28% | +$95.5K |
|
65
Gilead Sciences
GILD
$162B
| $433K | 0.03% |
6,705
+1,530
| +30% | +$98.7K |
|
66
Avantor
AVTR
$9.32B
| $422K | 0.03% |
+14,596
| New | +$421K |
|
67
ICU Medical
ICUI
$4.21B
| $419K | 0.03% |
2,039
+998
| +96% | +$211K |
|
68
CVS Health
CVS
$133B
| $415K | 0.03% |
5,519
+1,337
| +32% | +$97.4K |
|
69
United Therapeutics
UTHR
$25.8B
| $412K | 0.03% |
+2,466
| New | +$411K |
|
70
Becton Dickinson
BDX
$45.6B
| $404K | 0.03% |
1,704
| – | – |
|
71
Emergent Biosolutions
EBS
$373M
| $399K | 0.03% |
+4,294
| New | +$440K |
|
72
Perrigo
PRGO
$1.4B
| $398K | 0.03% |
9,823
+4,548
| +86% | +$195K |
|
73
Johnson & Johnson
JNJ
$618B
| $355K | 0.02% |
2,161
| – | – |
|
74
Sanofi
SNY
$103B
| $329K | 0.02% |
6,650
| – | – |
|
75
Pfizer
PFE
$143B
| $307K | 0.02% |
8,469
| – | – |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q1 2021 Portfolio in Review
As of Q1 2021, First Light Asset Management held 93 positions worth $1.51B, up 12% from $1.35B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
First Light Asset Management deployed $131M of net new capital in Q1 2021, opening 19 new positions and adding to 39 existing holdings. Its largest new stake was Cutera, Inc.: 1,244,117 shares worth $37.4M.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 86% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was CareDx, an estimated $44.6M trimmed.
- First Light Asset Management's largest Q1 2021 buy was Cutera, Inc.: 1,244,117 shares worth $37.4M.
- First Light Asset Management added most to Sutro Biopharma in Q1 2021, an estimated $29.2M increase.
- First Light Asset Management's biggest Q1 2021 reduction was CareDx, cutting an estimated $44.6M.
- First Light Asset Management fully exited Oxford Immunotec Global PLC Ordinary Shares in Q1 2021, selling an estimated $86.4M.
- First Light Asset Management's ten largest holdings make up 43% of its $1.51B portfolio in Q1 2021.
- First Light Asset Management opened 19 new positions and closed 16 in Q1 2021.
- First Light Asset Management's portfolio value rose 12% quarter-over-quarter to $1.51B.
Based on First Light Asset Management's 13F filing for Q1 2021, filed 17 May 2021.